Nymox Pharmaceutical Says Terminated Employment Of Each Of CFO Christopher Riley And COO Randall Lanham
Portfolio Pulse from Benzinga Newsdesk
Nymox Pharmaceutical has terminated the employment of CFO Christopher Riley and COO Randall Lanham. The company is currently searching for a new CFO and is in the process of hiring a general counsel to replace Mr. Lanham.
June 27, 2023 | 9:21 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Nymox Pharmaceutical has terminated its CFO and COO, which could lead to short-term instability in the company's management and operations.
The termination of key management personnel such as the CFO and COO can lead to short-term instability as the company searches for replacements. This could potentially impact the company's operations and financial management, which could negatively affect the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100